Lung Cancer: The Bad and the Worse


In terms of deaths caused by various forms of cancer, lung cancer ranks second only to breast cancer. The National Cancer Institute recently reported that an estimated 172,570 new cases of lung cancer will be reported this year and that 163,510 American will die from this disease.

Lung cancer is caused predominantly by smoking. One expert says that in the case of Small Cell Lung Carcinoma (cancer), it is almost always caused by smoking.

Lung cancer is called lung cancer because it begins in the lungs. The right lung has three sections, the left lung has two. Each section is called a lobe. Sometimes the term "bronchogenic cancer" is used to refer to lung cancer as most lung cancers begin in one of the two breathing tubes, the bronchi, in the lungs.

There are two major types of lung cancer. One is the Small Cell Lung Cancer (SCLC) mentioned in the previous paragraph. The other is Non-Small Cell Lung Cancer (NSCLC).

Non-Small Cell Lung Cancer has three subtypes: Adenocarcinoma, Squamous Cell Carcinoma and Large Cell Undifferentiated Carcinoma. NSCLC is the least "serious" of the two types. In fact, if it is detected early, it is possible that it can be cured with surgery.

Andenocarcinoma accounts for about 40 percent of lung cancer cases in the U.S. It is the most common cancer among women and can be seen in non-smokers. Squamous Cell Carcinoma represents about 30 to 35 percent of lung cancers and tends to stay localized in the chest longer than other types of lung cancer. Large Cell Undifferentiated Carcinoma represents only about five to 15 percent of lung cancers in the U.S. The incidence of this type of cancer seems to be decreasing.

The worst and most aggressive form of lung cancer is Small Cell Lung Cancer. It represents only about 15 to 20 percent of all lung cancers. It spreads to the lymph nodes and other organs more quickly than NSCLC, but seems more responsive to chemotherapy drugs.

Non-Small Cell Lung Cancer is described in stages ? Stage I through IV. WebMD recently reports survival rates of NSCLC as:

· Stage 1A or 1B with no lymph node involvement has a five-year survival rate of 43 to 64 percent when treated with surgery.

· Stage IIA or IIB with a single lymph node involvement, when treated with surgery, has a five-year survival rate of 20 to 40 percent.

· Stage IIIA with a single lymph node involvement in the center of the chest, when treated with surgery has a five-year survival rate of 15 to 25 percent.

· Stage IIIB with lymph node involvement in the chest and neck, when treated with radiation without other treatment, has a five-year survival rate of five to seven percent.

· Stage IIIB with lymph node involvement in the chest and neck, when treated with radiation and chemotherapy, has a five-year survival rate between seven and 17 percent.

· Stage IV with extensive lymph node involvement or cancer that has spread to other organs, hen treated with chemotherapy and palliative care to reduce symptoms and increase comfort has a one-year survival rate.

The prognosis is much bleaker for patients with Small Cell Lung Cancer. This form of cancer is found in two stages: limited or extensive. The limited version is that which is found in only one lung and nearby lymph nodes. The extensive type has spread outside the lung to other parts of the chest or body (metastasized). Limited SCLC when treated with chemotherapy and radiation therapy has an average survival time of 18 to 20 months. The extensive form of SCLC when treated with chemotherapy has a survival time of 10 to 12 months. Ttwo-year survival rate is one to three percent, and the five-year survival rate less than two percent.

The majority of people diagnosed with SCLC will die despite the best available treatment.

While surgery plays the most important part in the treatment of Non-Small Cell Lung Cancer, chemotherapy is always the chosen treatment for Small Cell Lung Cancer. In the case of limited stage SCLC, radiation therapy may also be used as the cancer is still localized to the chest area where radiation can be focused.

Small Cell Cancer Cells are so small they cannot be seen on scans. Even in the case of limited stage SCLC, it is possible for some cells to break away from the primary cancer and migrate to anywhere in the body. For this reason, chemotherapy is the preferred treatment as it treats the whole body, unlike radiation therapy which must be focused on a selected area. In act, chemotherapy is the preferred treatment for both limited and extensive stage Small Cell Lung Cancer.

Article by Douglas Hanna. Douglas is a retired advertising and marketing executive and long-time Denver resident. He is the webmaster of http://www.all-in-one-info.com, a free resource for information on a variety of subjects. Please visit his site to subscribe to his free newsletter, "Tips & Tricks to Save Money & Live Better."







Related News



Chemo for Mesothelioma Offers Limited Survival Benefits - Forbes

Chemo for Mesothelioma Offers Limited Survival Benefits
Forbes, NY -May 15, 2008
THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to ...

Tom Cruise > CELEBRITY SCIENTOLOGISTS AT RISK FROM ASBESTOS - Contactmusic.com

Contactmusic.com

Tom Cruise > CELEBRITY SCIENTOLOGISTS AT RISK FROM ASBESTOS
Contactmusic.com, UK -May 14, 2008
Dr. Coggins adds, "Once diagnosed with mesothelioma, the victim has six months to a year to live. It gradually reduces lung function until the victim is no ...

Doubts over asbestos cancer chemo - BBC News

Doubts over asbestos cancer chemo
BBC News, UK -May 15, 2008
"This is mainly because mesothelioma forms in the lining of the lung. This makes it hard to target." Kate Law, Cancer Research UK's director of clinical ...

Rosetta Genomics to Present Multiple Posters at the 44th Annual ... - Earthtimes (press release)

Rosetta Genomics to Present Multiple Posters at the 44th Annual ...
Earthtimes (press release), UK -14 hours ago
Rosetta Genomics' scientists investigated the microRNA expression profiles of lung mesothelioma and adenocarcinoma, and the potential of microRNAs as ...

Government, manufacturers face ¥6.6 billion damages claim - The Japan Times

The Japan Times

Government, manufacturers face ¥6.6 billion damages claim
The Japan Times, Japan -7 hours ago
A total of 172 people, mainly carpenters and plasterers, developed lung cancer, mesothelioma and other diseases after inhaling asbestos at work, ...

MolMed to present Phase II trial preliminary results for its ... - PharmaLive.com (press release)

MolMed to present Phase II trial preliminary results for its ...
PharmaLive.com (press release), PA -14 hours ago
Currently, single agent Phase II trials are ongoing in colorectal cancer, hepatocellular carcinoma, small-cell lung cancer and mesothelioma. ...

KATIE AND TOM IN ASBESTOS TERROR - Ok! Magazine

KATIE AND TOM IN ASBESTOS TERROR
Ok! Magazine, UK -May 15, 2008
If inhaled, asbestos particles can cause a deadly lung cancer called mesothelioma. The Church of Scientology cruise ship is often used to host birthday ...
Katie Holmes and Tom Cruise in death scareMyParkMag
Tom Cruise & Katie Holmes In Asbestos ScareEntertainmentwise
all 6 news articles

Cancer Research Group Releases Data - BusinessWeek

Cancer Research Group Releases Data
BusinessWeek -22 hours ago
... with advanced lung cancer. Those patients currently have few options. Alimta won Food & Drug Administration approval four years ago for mesothelioma, ...

Asbestos controversy aboard Scientology ship Freewinds - Men's News Daily

Asbestos controversy aboard Scientology ship Freewinds
Men's News Daily, CA -8 hours ago
Dr. Coggins went on to note that “Once diagnosed with mesothelioma, the victim has six months to a year to live. It gradually reduces lung function until ...


Lung cancer patients live longer with Alimta -study - guardian.co.uk

Lung cancer patients live longer with Alimta -study
guardian.co.uk, UK -May 15, 2008
Alimta is approved for a lung tumor called mesothelioma and also as a second-line treatment after progression for non-small-cell lung cancer. ...